CTOs on the Move

Atrion Medical Products

www.atrionmedical.com

 
Atrion Medical Products is a Arab, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Episode Solutions

Episode Solutions provides resources and services, tailored exclusively to the needs of musculoskeletal physicians and physicians groups, to help evaluate and maximize physician performance in alternative payment structures, without sacrificing existing professional fee-for-service revenue. Episode Solutions provides the platform that enables MSK physicians to take advantage of the substantial opportunities to create and share in immediate savings through bundled payments.

Healthy.io

Healthy.io transforms the smartphone camera into a medical device to deliver healthcare at the speed of life. The company`s at-home urinalysis and digitized wound care services enable providers and healthcare systems to close gaps in access and care while increasing patient satisfaction. Healthy.io is a global leader in digital health and is a recipient of the CNBC 2020 Disruptor 50 Award, Fast Company`s World`s Most Innovative Companies 2020 Award, and the Financial Times 2020 Boldness in Business Award. The company is based in Tel Aviv and has offices in Boston and London.

Novasyte

Novasyte partners with med-tech companies, offering outsourced commercial service teams for clinical, sales, field technical and recall support. Our flexible model enables us to build, deploy and manage teams that expand and contract to meet our clients` customer-facing needs. Program success is tracked and measured with our real-time business intelligence analytics that provide our clients with critical insights into their most important resources - their people and their customers.

PLANMECA USA

PLANMECA USA is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zenflow

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.